Fatal Malonyl CoA Decarboxylase Deficiency Due to Maternal Uniparental Isodisomy of the Telomeric End of Chromosome 16
Article first published online: 29 MAY 2007
Annals of Human Genetics
Volume 71, Issue 6, pages 705–712, November 2007
How to Cite
Malvagia, S., Papi, L., Morrone, A., Donati, M. A., Ciani, F., Pasquini, E., La Marca, G., Scholte, H. R., Genuardi, M. and Zammarchi, E. (2007), Fatal Malonyl CoA Decarboxylase Deficiency Due to Maternal Uniparental Isodisomy of the Telomeric End of Chromosome 16. Annals of Human Genetics, 71: 705–712. doi: 10.1111/j.1469-1809.2007.00373.x
- Issue published online: 29 MAY 2007
- Article first published online: 29 MAY 2007
- Received: 5 December 2006 Accepted: 19 April 2007
- malonic aciduria;
- malonyl-CoA decarboxylase;
- uniparental disomy;
Malonic aciduria is a rare autosomal recessive disorder caused by deficiency of malonyl-CoA decarboxylase, encoded by the MLYCD gene.
We report on a patient with clinical presentation in the neonatal period. Metabolic investigations led to a diagnosis of malonyl-CoA decarboxylase deficiency, confirmed by decreased activity in cultured fibroblasts. High doses of carnitine and a diet low in lipids led to a reduction in malonic acid excretion, and to an improvement in his clinical conditions, but at the age of 4 months he died suddenly and unexpectedly. No autopsy was performed.
Molecular analysis of the MLYCD gene performed on the proband's RNA and genomic DNA identified a previously undescribed mutation (c.772–775delACTG) which was homozygous. This mutation was present in his mother but not in his father; paternity was confirmed by microsatellite analysis. A hypothesis of maternal uniparental disomy (UPD) was investigated using fourteen microsatellite markers on chromosome 16, and the results confirmed maternal UPD. Maternal isodisomy of the 16q24 region led to homozygosity for the MLYCD mutant allele, causing the patient's disease. These findings are relevant for genetic counselling of couples with a previously affected child, since the recurrence risk in future pregnancies is dramatically reduced by the finding of UPD. In addition, since the patient had none of the clinical manifestations previously associated with maternal UPD 16, this case provides no support for the existence of maternally imprinted genes on chromosome 16 with a major effect on phenotype.